DBM-43H11 series (Discovery BioMed)

N/A

Report date: 2025/03/18 18:16:50
NME

Base Information

Drug NameDBM-43H11 series (Discovery BioMed)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsCell cycle inhibitors
TargetsUpdating
Therapy Area/IndicationsPolycystic Kidney DiseasesGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDiscovery BioMed Inc
China Registration ClassN/A

Develop Information

Active CompaniesDiscovery BioMed Inc
Inactive CompaniesN/A
Active IndicationsPolycystic Kidney DiseasesGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A